Sun Pharmaceutical Industries Q3 Results
- BSE: 524715
- NSE: SUNPHARMA
- ISIN: INE044A01036
- Sector: Biotechnology & Drugs
BSE
1,704
-4.05 (-0.24%)
-4.05 (-0.24%)Volume22.71 K
Updated: Thu 15 May, 2025 | 12:48:59
NSE
1,703.80-4.40 (-0.26%)
-4.40 (-0.26%)Volume1.45 M
Updated: Thu 15 May, 2025 | 12:36:44
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹13,675.46 Cr.(10.46%)
- Operating Profit₹3,245.64 Cr.(22.00%)
- Profit After Tax₹2,903.38 Cr.(15.04%)
- Operating Margin23.73%(10.45%)
Note: Comparison is on YoY basis
Quarterly - Sun Pharmaceutical Industries Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 23 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 13,675.46 | 12,192.41 | 2.89% | 12,380.70 | 10.46% |
| Selling/ General/ Admin Expenses Total | 2,552.28 | 2,364.36 | 3.01% | 2,363.32 | 8.00% |
| Depreciation/ Amortization | 630.56 | 632.82 | 0.74% | 622.14 | 1.35% |
| Other Operating Expenses Total | 4,190.27 | 3,827.49 | -2.75% | 3,928.17 | 6.67% |
| Total Operating Expense | 10,429.82 | 9,611.76 | 3.20% | 9,720.38 | 7.30% |
| Operating Income | 3,245.64 | 2,580.65 | 1.91% | 2,660.32 | 22.00% |
| Net Income Before Taxes | 3,476.40 | 2,790.88 | -3.38% | 3,000.35 | 15.87% |
| Net Income | 2,903.38 | 2,375.51 | -4.50% | 2,523.75 | 15.04% |
| Diluted Normalized EPS | 13.21 | 9.90 | 3.98% | 10.75 | 22.86% |